46MO Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
Titel:
46MO Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
Auteur:
Adusumilli, P.S. Amador, A.M. Chintala, N. Hou, Z. Offin, M. Pineda, J. Senechal, B. Quach, H.T. Bellis, R. Banerjee, S. Saini, J. Zhu, A. Daly, R.M. Sadelain, M. Rivière, I. Zauderer, M. O'Cearbhaill, R.